Dow Up 0.07% Nasdaq Up 0.61%

Incyte Corporation (INCY)

-NasdaqGS
75.01 Up 1.87(2.56%) Nov 26, 4:00PM EST
|After Hours : 75.00 Down 0.01 (0.01%) Nov 26, 4:41PM EST
Prev Close:73.14
Open:73.10
Bid:50.50 x 100
Ask:N/A
1y Target Est:81.08
Beta:0.18
Earnings Date:Feb 10 - Feb 16 (Est.)
Day's Range:72.82 - 75.01
52wk Range:40.30 - 75.88
Volume:804,565
Avg Vol (3m):1,233,700
Market Cap:12.67B
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYUp 2.56%12.67B
AMGNUp 1.53%125.30B
CELGUp 1.39%89.94B
RHHBYUp 0.54%254.20B

Key Statistics

Forward P/E (1 yr):357.19
P/S (ttm):25.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.13
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-6.88

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback